Home Media/Press releases/First financing round>
Latest News
See all news


Press release

First financing round

Lyon, France, November 22nd, 2010 – Orega Biotech, a new venture originally backed by Octalfa SAS and Inserm Transfert, which was set up in early 2010 to develop new cancer therapies, announces today that it has raised € 1 million of funding. New investors, SHAM, a Lyon-based insurance company specialized in medical malpractice liability insurance, Rhône-Alpes Création, a private Venture Capital Company (RSC) which invests in innovative start-ups based in the Rhone-Alpes region and Inserm Transfert Initiative, joined the historical investor Octalfa SAS, a French holding company managed by Gilles Alberici. 

Download the press release.

See all our press releases

See all events